Home
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine Market Share Analysis for August 2026

恒瑞医药是一家从事创新和高品质药品研制及推广的民族制药企业，已发展成为国内知名的抗肿瘤药、手术用药和影像介入产品的供应商。2020年，公司入选全球投行torreya公布的全球1000强药企榜单，位列第21位。在美国制药经理人杂志（pharmexec）公布的2021年全球制药企业top50榜单中，恒瑞医药排名连续三年攀升，位列第38位

Health > Biotechnology and Pharmaceuticals

Domainhengrui.com

Year Founded1970

Employees> 10001

Annual Revenue--

Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (including company regionals)

hengrui.com

See more website traffic and engagement information

Jiangsu Hengrui Medicine Stock price in August 2026

Jiangsu Hengrui Medicine stock is traded under the ticker #1276. Below you can review Jiangsu Hengrui Medicine stock performance in the past 12 months up to August 2026

Total visits to Jiangsu Hengrui Medicine's top domains

Understand Jiangsu Hengrui Medicine market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

hengrui.com258K

See more with Sales Intelligence

Avg. visit duration in Jiangsu Hengrui Medicine's top domains

Analyze Jiangsu Hengrui Medicine engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

hengrui.com00:09:48

See more with Sales Intelligence

Avg. pageviews on Jiangsu Hengrui Medicine's top domains

See how Jiangsu Hengrui Medicine keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

hengrui.com7.74

See more with Sales Intelligence

Jiangsu Hengrui Medicine top competitors by domain

Top similar sites in August 2026, ranked by their affinity

medincell.comCompany NameMedinCellEmployees51 - 200HQFrance, JacouAnnual revenue$10M - $15MTotal visits6.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Jiangsu Hengrui Medicine

These are the website technologies, by industry, used by Jiangsu Hengrui Medicine top domains

Mobile (3)

Meta Viewport

Advertising (2)

PubMatic

Conversion & Analytics (1)

Baidu Analytics

eCommerce (1)

Vtex Enterprise

More Technologies

3

See all

News & Signals from Jiangsu Hengrui Medicine

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsElevar Therapeutics, Inc. partnered with Hengrui on Jul 1st '26.Elevar is working with Hengrui Pharma to address the identified issues and prepare for resubmission.

NewsHengrui had revenue of $1.07B on Jun 30th '26.Based on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of HK$8.42 billion and a net profit of HK$2.51 billion.

NewsHengrui had earnings of $326M on Jun 1st '26.For the most recent quarter through June, Hengrui achieved a net profit of 2.2 billion yuan ($326.5 million), a Reuters calculation showed, compared with an average analyst forecast of 2.9 billion yuan, according to LSEG data.